These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 37149607)

  • 41. Research progress of whole-cell-SELEX selection and the application of cell-targeting aptamer.
    Duan Y; Zhang C; Wang Y; Chen G
    Mol Biol Rep; 2022 Aug; 49(8):7979-7993. PubMed ID: 35274201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developing Aptamers by Cell-Based SELEX.
    Catuogno S; Esposito CL; de Franciscis V
    Methods Mol Biol; 2016; 1380():33-46. PubMed ID: 26552814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-SELEX: in vitro selection of synthetic small specific ligands.
    Dickinson H; Lukasser M; Mayer G; Hüttenhofer A
    Methods Mol Biol; 2015; 1296():213-24. PubMed ID: 25791604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hybrid-Type SELEX for the Selection of Artificial Nucleic Acid Aptamers Exhibiting Cell Internalization Activity.
    Uemachi H; Kasahara Y; Tanaka K; Okuda T; Yoneda Y; Obika S
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aptamer Nanoconstructs Crossing Human Blood-Brain Barrier Discovered via Microphysiological System-Based SELEX Technology.
    Choi JW; Seo M; Kim K; Kim AR; Lee H; Kim HS; Park CG; Cho SW; Kang JH; Joo J; Park TE
    ACS Nano; 2023 May; 17(9):8153-8166. PubMed ID: 37068137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generating aptamers by cell-SELEX for applications in molecular medicine.
    Ye M; Hu J; Peng M; Liu J; Liu J; Liu H; Zhao X; Tan W
    Int J Mol Sci; 2012; 13(3):3341-3353. PubMed ID: 22489154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics.
    Gholikhani T; Kumar S; Valizadeh H; Mahdinloo S; Adibkia K; Zakeri-Milani P; Barzegar-Jalali M; Jimenez B
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toward the Selection of Cell Targeting Aptamers with Extended Biological Functionalities to Facilitate Endosomal Escape of Cargoes.
    Tawiah KD; Porciani D; Burke DH
    Biomedicines; 2017 Aug; 5(3):. PubMed ID: 28837119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical applications of nucleic acid aptamers in cancer.
    Pei X; Zhang J; Liu J
    Mol Clin Oncol; 2014 May; 2(3):341-348. PubMed ID: 24772298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nucleic acid aptamers targeting cell-surface proteins.
    Dua P; Kim S; Lee DK
    Methods; 2011 Jun; 54(2):215-25. PubMed ID: 21300154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX.
    Lyu Y; Chen G; Shangguan D; Zhang L; Wan S; Wu Y; Zhang H; Duan L; Liu C; You M; Wang J; Tan W
    Theranostics; 2016; 6(9):1440-52. PubMed ID: 27375791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aptamers: potential applications to pancreatic cancer therapy.
    Rialon KL; White RR
    Anticancer Agents Med Chem; 2011 Jun; 11(5):434-41. PubMed ID: 21492073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.
    Shum KT; Zhou J; Rossi JJ
    J Cancer Ther; 2013 Jun; 4(4):872-890. PubMed ID: 25057429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of DNA aptamers specific for small therapeutic peptides using a modified SELEX method.
    Lee J; Ryu M; Bae D; Kim HM; Eyun SI; Bae J; Lee K
    J Microbiol; 2022 Jul; 60(7):659-667. PubMed ID: 35731347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation of Natural DNA Aptamers for Challenging Small-Molecule Targets, Cannabinoids.
    Yu H; Luo Y; Alkhamis O; Canoura J; Yu B; Xiao Y
    Anal Chem; 2021 Feb; 93(6):3172-3180. PubMed ID: 33528997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Highlight of Recent Advances in Aptamer Technology and Its Application.
    Sun H; Zu Y
    Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aptamers targeting cell surface proteins.
    Takahashi M
    Biochimie; 2018 Feb; 145():63-72. PubMed ID: 29198584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.